Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 03, 2026 23:21 ET | Source: The Rosen Law Firm PA

PEABODY ENERGY DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Peabody Energy Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – BTU

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Peabody Energy Corporation (NYSE: BTU) between October 14,...
August 03, 2026 23:17 ET | Source: The Rosen Law Firm PA

BlackRock Investor News: If You Have Suffered Losses in BlackRock, Inc. Mutual Funds, You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of investors in BlackRock, Inc....
August 03, 2026 23:06 ET | Source: The Rosen Law Firm PA

Alibaba Investor News: If You Have Suffered Losses in Alibaba Group Holding Limited (NYSE: BABA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Alibaba...
August 03, 2026 23:05 ET | Source: Abbott Cooper PLLC

KLRS: Abbott Cooper PLLC Announces Investigation on Behalf of Kalaris Therapeutics, Inc. (Formerly Allovir, Inc.) Stockholders

Abbott Cooper PLLC is investigating fiduciary duty claims for Kalaris Therapeutics (formerly AlloVir) holders who owned shares before November 7, 2024.
August 03, 2026 23:00 ET | Source: Rapid Nutrition Plc

Rapid Nutrition Joins Global Conversation on the Future of AI-Driven HealthTech

LONDON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Rapid Nutrition PLC (Euronext Growth: ALRPD), today advised shareholders that its long-term HealthTech strategy continues to attract recognition from...
August 03, 2026 22:48 ET | Source: InnoCare Pharma

InnoCare Announces Orelabrutinib in Combination with Mesutoclax Granted Breakthrough Therapy Designation in China

Orelabrutinib in combination with mesutoclax has been granted BTD for the treatment of patients with MZL who have received at least one prior therapy.
August 03, 2026 22:42 ET | Source: ArtArch

ArtArch Merges All Products into Unified Platform, Elevates Positioning to "AI-Native Creative OS"

SINGAPORE, Aug. 03, 2026 (GLOBE NEWSWIRE) -- The AI video generation landscape has evolved from an exciting frontier into a collective sense of drift. Generation speeds keep breaking records, yet...
August 03, 2026 22:00 ET | Source: The Rosen Law Firm PA

ROSEN, THE FIRST FILING FIRM, Encourages DNOW Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – DNOW

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces it announces it has filed a class action lawsuit on behalf of all persons or entities...
August 03, 2026 21:35 ET | Source: ARC Group Securities Acquisition I

ARC Group Securities Acquisition I Announces Pricing of $105,000,000 Initial Public Offering

NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- ARC Group Securities Acquisition I (the “Company”) announced today the pricing of its initial public offering of 10,500,000 units at a price of $10.00 per...
August 03, 2026 21:32 ET | Source: Troutman Amin, LLP

Troutman Amin, LLP Drops Deserve to Win Podcast Ep. 44 Featuring Interviews with Three Ceos Discussing the Future of Telecom

IRVINE, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Deserve to Win Podcast Episode 44 just dropped and Troutman Amin, LLP’s new format, new rules, and awesome guests have received rave reviews from...